Biodistribution of a potential chemotherapeutic, dinuclearbisphosphinogold(I) dithiocarbamate, as determined by its 198Au radiolabelled analogue
| dc.contributor.author | Kriel, Frederik H. | |
| dc.contributor.author | Bester, Cornelius J. | |
| dc.contributor.author | Zeevaart, Jan Rijn | |
| dc.contributor.author | Szucs, Zoltan | |
| dc.contributor.author | Van Staden, Johan A. | |
| dc.contributor.researchID | 10070095 - Bester, Cornelius Johannes Jacobus | |
| dc.contributor.researchID | 16951484 - Zeevaart, Jan Rijn | |
| dc.date.accessioned | 2016-08-19T07:26:20Z | |
| dc.date.available | 2016-08-19T07:26:20Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | Dinuclearbisphosphinogold(I) dithiocarbamato, BPDTC, was previously found to have antitumour activity in vitro. 198Au radiolabelled BPDTC (radiochemical yield of 70 ± 6 % and radiochemical purity of[95 %) was used to determine its in vivo biodistribution in Sprague-Dawley rats. Gamma scintigraphs were performed over a period of 48 h and final radioactivity measurements of harvested organs of the test animals after termination was performed at 2, 4 and 48 h. The study successfully showed the biodistribution of the gold complex, with the highest uptake of the compound being observed in the lungs, liver and spleen | en_US |
| dc.description.sponsorship | Nuclear Technologies in Medicine and the Biosciences Initiative (NTeMBI), a national technology platform developed and managed by the South African Nuclear Energy Corporation (Necsa) and funded by the Department of Science and Technology. Biomed (Mintek) | en_US |
| dc.identifier.citation | Kriel, F.H. et al. 2015. Biodistribution of a potential chemotherapeutic, dinuclearbisphosphinogold(I) dithiocarbamate, as determined by its 198Au radiolabelled analogue. Journal of radioanalytical and nuclear chemistry, 303(3):1949-1954. [https://doi.org/10.1007/s10967-014-3816-4] | en_US |
| dc.identifier.issn | 0236-5732 | |
| dc.identifier.issn | 1588-2780 (Online) | |
| dc.identifier.uri | http://hdl.handle.net/10394/18326 | |
| dc.identifier.uri | https://link.springer.com/article/10.1007%2Fs10967-014-3816-4 | |
| dc.identifier.uri | https://doi.org/10.1007/s10967-014-3816-4 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.subject | Radiolabelling | en_US |
| dc.subject | 198Au | en_US |
| dc.subject | Gold(I) | en_US |
| dc.subject | Bisphosphine | en_US |
| dc.subject | Dithiocarbamate | en_US |
| dc.subject | Biodistribution | en_US |
| dc.title | Biodistribution of a potential chemotherapeutic, dinuclearbisphosphinogold(I) dithiocarbamate, as determined by its 198Au radiolabelled analogue | en_US |
| dc.type | Article | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.61 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
